Shortwave Diathermy for Muscle Mitochondrial Enhancement and Atrophy Mitigation ID: 2016-055

A novel intervention that utilizes shortwave diathermy to enhance muscle mitochondrial capacity and mitigate muscle atrophy without the need for physical exercise.

Technology Overview

This technology introduces an alternative treatment method using high-frequency electromagnetic waves in pulsed mode to mimic the effects of exercise by deeply heating muscles. It is designed for individuals unable to perform physical activities due to injury, illness, or age, offering a non-pharmacological solution to prevent muscle wasting conditions such as those associated with disuse, immobilization, aging, spaceflight, and cancer cachexia.

Key Advantages

• First non-pharmacological approach to combat muscle atrophy
• Promotes muscle sparing and enhances mitochondrial capacity, similar to exercise benefits
• Applicable to a wide range of individuals, including those who are injured, sick, or elderly
• Potential to be patented due to its novel application of shortwave diathermy for muscle sparing

Problems Addressed

• Muscle wasting conditions associated with disuse or immobilization
• Limitations in treatment options for individuals unable to engage in physical exercise
• Need for non-pharmacological treatments for muscle atrophy

Market Applications

• Medical devices for rehabilitation centers and hospitals
• Home healthcare equipment for individuals with limited mobility
• Therapeutic solutions for the elderly, injured, or those with chronic diseases leading to muscle atrophy
• Potential use in spaceflight and astronaut health maintenance

Additional Information

Technology ID: 2016-055
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 28 March, 2025